{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:31:59Z","timestamp":1790181119263,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jhlto.2025.100380","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T09:21:18Z","timestamp":1755768078000},"page":"100380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The burden of skin cancer in heart transplant recipients: Impact of immunosuppressive regimens"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4118-8930","authenticated-orcid":false,"given":"Matteo","family":"Marro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Roccuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Simonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Alfredo Sobrino","family":"Avellaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3689-0477","authenticated-orcid":false,"given":"Antonio","family":"Loforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ribero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Boffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2025.100380_bib1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time","volume":"36","author":"Lund","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/tri.13520","article-title":"Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines","volume":"32","author":"Crow","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhlto.2025.100380_bib3","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/jdv.15538","article-title":"Skin cancer in organ transplant recipients: dynamics in the incidence and clinical predictors for the first and subsequent post-transplant non-melanoma skin cancer","volume":"33","author":"Hartmann","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jhlto.2025.100380_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00403-024-03759-7","article-title":"Incidence and risk factors for skin cancer after heart transplantation: a systematic review and meta-analysis","volume":"317","author":"Yang","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jhlto.2025.100380_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bjd\/ljae092","article-title":"Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma","volume":"191","author":"Ribero","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jhlto.2025.100380_bib6","unstructured":"Clinical prediction models: a practical approach to development, validation, and updating. SpringerLink. Available at:\u00a0https:\/\/link.springer.com\/book\/10.1007\/978\u20133-030\u201316399-0, accessed March 26, 2025."},{"key":"10.1016\/j.jhlto.2025.100380_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.healun.2021.07.015","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult heart transplantation report - 2021; focus on recipient characteristics","volume":"40","author":"Khush","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib8","article-title":"Malignancies after heart transplantation","volume":"37","author":"Stenman","year":"2024","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhlto.2025.100380_bib9","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/ajt.13863","article-title":"Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis","volume":"16","author":"Jiyad","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib10","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1016\/j.ajt.2024.01.016","article-title":"OPTN\/SRTR 2022 Annual Data Report: Heart","volume":"24","author":"Colvin","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":"Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib13","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/00007890-200111270-00015","article-title":"Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the Joint UNOS\/ISHLT Thoracic Registry","volume":"72","author":"Hosenpud","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jhlto.2025.100380_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/403280","article-title":"Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors","volume":"2013","author":"Zaza","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jhlto.2025.100380_bib15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib16","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/j.1600-6143.2008.02386.x","article-title":"Skin cancer in organ transplant recipients\u2014where do we stand today?","volume":"8","author":"Ulrich","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000535040","article-title":"Predictors of recurrence and progression in poorly differentiated cutaneous squamous cell carcinomas: insights from a real-life experience","volume":"240","author":"Roccuzzo","year":"2024","journal-title":"Dermatol Basel Switz"},{"key":"10.1016\/j.jhlto.2025.100380_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12387","article-title":"Updates in skin cancer in transplant recipients and immunosuppressed patients: review of the 2022\u20132023 scientific symposium of the international immunosuppression and transplant skin cancer collaborative","volume":"37","author":"Pisano","year":"2024","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhlto.2025.100380_bib19","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.mayocp.2022.07.004","article-title":"Skin cancer in solid organ transplant recipients: a review for the nondermatologist","volume":"97","author":"Berman","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhlto.2025.100380_bib20","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3390\/cells12202441","article-title":"Immunity against non-melanoma skin cancer and the effect of immunosuppressive medication on non-melanoma skin cancer risk in solid organ transplant recipients","volume":"12","author":"Bakker","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jhlto.2025.100380_bib21","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00403-023-02646-x","article-title":"A review of heart transplant immunosuppressants and nonmelanoma skin cancer","volume":"315","author":"Eckembrecher","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jhlto.2025.100380_bib22","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.3390\/cancers16173083","article-title":"Cutaneous squamous cell carcinoma in patients with solid-organ-transplant-associated immunosuppression","volume":"16","author":"Khaddour","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jhlto.2025.100380_bib23","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.3390\/curroncol30060430","article-title":"Systematic review of calcineurin inhibitors and incidence of skin malignancies after kidney transplantation in adult patients: a study of 309,551 cases","volume":"30","author":"Kulbat","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jhlto.2025.100380_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","article-title":"Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the Skin Cancer after Organ Transplant (SCOT) cohort","volume":"16","author":"Coghill","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib25","series-title":"The Pathology of Cardiac Transplantation","first-page":"329","article-title":"Malignancies after heart transplantation","author":"Agostini","year":"2016"},{"key":"10.1016\/j.jhlto.2025.100380_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/bjd.17345","article-title":"Azathioprine: friend or foe?","volume":"180","author":"Leigh","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jhlto.2025.100380_bib27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1432-2277.2009.01010.x","article-title":"Effect of everolimus on skin cancers in calcineurin inhihitor-treated heart transplant recipients","volume":"23","author":"Euvrard","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhlto.2025.100380_bib28","first-page":"93","article-title":"Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy","volume":"9","author":"Rivinius","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jhlto.2025.100380_bib29","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.jacc.2019.03.499","article-title":"Incidence of malignancies in patients treated with sirolimus following heart transplantation","volume":"73","author":"Asleh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhlto.2025.100380_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.6002\/ect.2022.0252","article-title":"Skin cancer risk prediction in heart transplant recipients","volume":"21","author":"Nair","year":"2023","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib31","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.mayocp.2018.04.025","article-title":"Immunosuppression, race, and donor-related risk factors affect de novo cancer incidence across solid organ transplant recipients","volume":"93","author":"Bhat","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhlto.2025.100380_bib32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jamadermatol.2019.0692","article-title":"Incidence and risk factors of keratinocyte carcinoma after first solid organ transplant in Ontario, Canada","volume":"155","author":"Park","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jhlto.2025.100380_bib33","article-title":"Post-transplant malignancy in solid organ transplant recipients in Ireland, the Irish Transplant Cancer group","volume":"33","author":"O\u2019Neill","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhlto.2025.100380_bib34","first-page":"662","article-title":"Cutaneous complications of immunosuppression in 812 transplant recipients: a 40-year single center experience","volume":"155","author":"Infusino","year":"2020","journal-title":"G Ital Dermatol E Venereol"},{"key":"10.1016\/j.jhlto.2025.100380_bib35","article-title":"Malignancies after heart transplantation","volume":"37","author":"Stenman","year":"2024","journal-title":"Transpl Int"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425001752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425001752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:54:32Z","timestamp":1763027672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133425001752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"alternative-id":["S2950133425001752"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100380","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of skin cancer in heart transplant recipients: Impact of immunosuppressive regimens","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100380"}}